RT Journal Article
SR Electronic
T1 Segregating the Frontal Cortex with Deep Brain Stimulation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.07.23286766
DO 10.1101/2023.03.07.23286766
A1 Hollunder, Barbara
A1 Ostrem, Jill L.
A1 Sahin, Ilkem Aysu
A1 Rajamani, Nanditha
A1 Oxenford, Simón
A1 Butenko, Konstantin
A1 Polosan, Mircea
A1 Akram, Harith
A1 Vissani, Matteo
A1 Zhang, Chencheng
A1 Sun, Bomin
A1 Reich, Martin M.
A1 Volkmann, Jens
A1 Finke, Carsten
A1 Kühn, Andrea A.
A1 Bergman, Hagai
A1 DeLong, Mahlon R.
A1 Mazzoni, Alberto
A1 Romito, Luigi M.
A1 Zrinzo, Ludvic
A1 Joyce, Eileen M.
A1 Chabardes, Stephan
A1 Starr, Philip A.
A1 Li, Ningfei
A1 Horn, Andreas
YR 2023
UL http://medrxiv.org/content/early/2023/03/09/2023.03.07.23286766.abstract
AB The frontal cortex is involved in motor, cognitive, and affective brain functions. In humans, however, neuroanatomy-function mappings are predominantly derived from correlative neuroimaging studies. Hence, exactly which frontal domains causally mediate which function remains largely elusive. Herein, we leverage a strategy that allows for causal inference using invasive neuromodulation. Studying 394 subthalamic deep brain stimulation electrodes in patients suffering from one of four brain disorders, we segregated the frontal cortex into cortical projection sites of modulated circuits by their involvement in specific functions. Modulating projections from sensory and motor cortices in dystonia, from primary motor cortex in Tourette’s syndrome, from supplementary motor cortex in Parkinson’s disease, and from ventromedial prefrontal, anterior cingulate, dorsolateral prefrontal and orbitofrontal cortices in obsessive-compulsive disorder linked to respective symptom improvements. Our findings showcase the combination of deep brain stimulation and brain connectomics as a tool for causal inference on structure-function mappings within the human brain.Competing Interest StatementJ.L.O. reports research grant support from Medtronic and Boston Scientific and is a consultant for Abbott, outside of the submitted work. M.M.R. reports grant support and honoraria for speaking from Medtronic and Boston Scientific, outside of the submitted work. J.V. reports grants and personal fees from Medtronic Inc., grants and personal fees from Boston Scientific, personal fees from Abbott, outside of the submitted work. H.B. is consultant of Alpha-Omega, outside of the submitted work. S.C. is consultant for Medtronic and Boston Scientific, outside of the submitted work. A.H. reports lecture fees from Boston Scientific, outside of the submitted work. B.H., I.A.S., N.R., S.O., K.B., M.P., H.A., M.V., C.Z., B.S., C.F., A.A.K., M.R.D., A.M., L.M.R., L.Z., E.M.J., P.A.S., and N.L. report no competing interests.Funding StatementB.H. and I.A.S. were supported via a scholarship from the Einstein Center for Neurosciences Berlin. The work conducted at the University of California San Francisco (J.L.O. and P.A.S.) received support by a grant from the Benign Essential Blepharospasm Research Foundation and philanthropic support from Larry and Kana Miao. M.V. was supported by institutional funds from Scuola Superiore Sant'Anna. Further, this work received support by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation): 424778381-TRR 295 to M.M.R., J.V, A.A.K., H.B., A.H. and NL, 347325977 to A.A.K., FI 2309/1-1 and FI 2309/2-1 to C.F. L.M.R. was supported by the Italian Ministry of Health grant GR-2009-1594645. AH was moreover supported by Deutsches Zentrum fuer Luft-und Raumfahrt (DynaSti grant within the EU Joint Programme Neurodegenerative Disease Research, JPND), the National Institutes of Health (R01 13478451, 1R01NS127892-01 & 2R01 MH113929) as well as the New Venture Fund (FFOR Seed Grant).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All analyses performed for the purpose of the present manuscript were approved by the institutional review board of Charite - Universitaetsmedizin Berlin (master vote EA2/186/18) and treatment of data complied with all relevant ethical regulations.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesClinical outcome and imaging data cannot be publicly shared as this would compromise patient privacy according to current data protection regulations. It is, however, available from the principal investigators of the collecting sites upon reasonable request within the framework of a data sharing agreement. The sweet tract atlas and sweet spots of all four disorders are openly available within Lead-DBS software (www.lead-dbs.org). Further, the DBS Tractography Atlas, v2 can be openly downloaded via the Lead-DBS knowledge base (https://www.lead-dbs.org/helpsupport/knowledge-base/atlasesresources/normative-connectomes/). The Human Connectome Project (HCP) 1,065 diffusion source data (Yeh et al., 2016, PLoS Comput. Biol.) used to inform this atlas can be openly accessed via DSI-Studio (https://sites.google.com/a/labsolver.org/brain/diffusion-mri-data/hcp-dmri-data). The following normative resources have been made openly available by the original authors: the MGH 760 um Connectome (Edlow et al., 2019, Sci. Data)(https://datadryad.org/stash/dataset/doi:10.5061/dryad.nzs7h44q2) and the Basal Ganglia Pathway Atlas (Petersen et al., 2019, Neuron) (https://osf.io/mhd4z/). While a processed version of the HCP 985 Connectome (as described in Li et al., 2020, Nat. Commun) can be requested from the corresponding authors, source data (Van Essen et al., 2013, Neuroimage) are freely accessible via the repository of the HCP (https://www.humanconnectome.org/study/hcp-young-adult/document/1200-subjects-data-release).https://www.lead-dbs.org/helpsupport/knowledge-base/atlasesresources/normative-connectomes/ https://sites.google.com/a/labsolver.org/brain/diffusion-mri-data/hcp-dmri-data https://datadryad.org/stash/dataset/doi:10.5061/dryad.nzs7h44q2https://osf.io/mhd4z/https://www.humanconnectome.org/study/hcp-young-adult/document/1200-subjects-data-releaseANTsAdvanced Normalization ToolsBFMDRSBurke-Fahn-Marsden Dystonia Rating ScaleCIT168 atlasCalifornia Institute of Technology reinforcement learning atlasCTcomputed tomographyDBSdeep brain stimulationDISTALDBS intrinsic template atlasdMRIdiffusion-weighted magnetic resonance imagingDYTdystoniaE-fieldelectric field magnitudeFEMfinite element methodfMRIfunctional magnetic resonance imagingGPeexternal pallidum (globus pallidus, external segment)GPiinternal pallidum (globus pallidus, internal segment)HCPHuman Connectome ProjectJHU atlasJohns Hopkins University atlasMGHMassachusetts General HospitalMNI spaceICBM 2009b Non-linear Asymmetric template spaceM1primary motor cortexMRImagnetic resonance imagingOCDobsessive-compulsive disorderPDParkinson’s diseasePaCER algorithmPrecise and Convenient Electrode Reconstruction for Deep Brain Stimulation algorithmSMAsupplementary motor areaSPM12 softwareStatistical Parametric Mapping softwareSTNsubthalamic nucleusSyN approachSymmetric Normalization approachTRAC/CORE algorithmtrajectory search/contact reconstructions algorithmTSTourette’s syndromeUPDRS-IIIUnified Parkinson’s Disease Rating Scale – Part IIIY-BOCSYale-Brown Obsessive-Compulsive ScaleYGTSSYale Global Tic Severity Scale